SCHEMBL14416156

SCHEMBL14416156

CCC1CC2c3cccnc3NC2N1C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13245239 0.83 HTR2A (0.33) —
SCHEMBL14408314 0.82 TNKS2 (0.31) —
SCHEMBL14415876 0.80 EHMT2 (0.33) —
SCHEMBL12416272 0.77 IDH1 (0.32) —
SCHEMBL13267096 0.76 ADORA3 (0.33) —
SCHEMBL13267448 0.72 HTR2A (0.33) —
SCHEMBL13245075 0.68 TNKS2 (0.30) —
SCHEMBL12213778 0.68 TNKS2 (0.33) —
SCHEMBL15100542 0.68 IDH1 (0.32) —
SCHEMBL12507312 0.67 IDH1 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7273885-B2 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-09-25 — — US disclosed
Send feedback